migraine
New Research Links Higher Diastolic Blood Pressure With Migraines
A new study has found that women with higher diastolic blood pressure are more likely to have migraines, indicating ...
SEPTEMBER 18, 2024
FDA Approves Qulipta for Chronic Migraine
The FDA expanded the indication for Qulipta for the preventive treatment of migraine in adults.
APRIL 18, 2023
FDA Approves Zavzpret Nasal Spray to Treat Migraine
The FDA approved Zavzpret, the first calcitonin gene–related peptide receptor antagonist nasal spray, for the ...
MARCH 15, 2023
Test Predicts Response to Key Migraine Therapy With 86% Accuracy
A quick, inexpensive and noninvasive proprietary test is an 86% accurate pretreatment predictor of anti-calcitonin ...
MARCH 13, 2023
Celecoxib Oral Solution Provides Relief From Pain, Other Symptoms of Headache
Patients treated with celecoxib oral solution reported two-hour, post-dose relief from headache pain, phonophobia ...
JANUARY 11, 2023
FDA Approves First Oral CGRP Receptor Antagonist Specifically Developed for Migraine Prevention
The FDA approved atogepant for the preventive treatment of episodic migraine in adults.
OCTOBER 8, 2021
Study Shows Anti-CGRP Monoclonal Antibody Agents as Future Treatment for Neuropathic Pain
A study has used a novel approach to treat neuropathic pain effectively with monoclonal antibodies that block ...
SEPTEMBER 15, 2021
Despite Risks, Opioid Scripts Remain High For Migraine
A study assessing the value of opioids in treating migraine headaches has reconfirmed previous findings that the ...
FEBRUARY 17, 2020
CGRP Inhibitors Make Their Mark In Migraine Rx
Boston—The advent of three new high-cost, monthly injectable medications for migraine has brought this highly ...
AUGUST 22, 2019
AAN Issues Guidelines for Pediatric Migraine Treatment
New guidelines issued for pediatric migraine management. Looks at managing both acute migraine and preventive ...
AUGUST 15, 2019
FDA Approves Emgality for Migraine Prevention
The FDA approved galcanezumab-gnlm (Emgality, Eli Lilly) to prevent migraine in adults.
SEPTEMBER 28, 2018
FDA Approves Ajovy for Migraine Prevention
The FDA approved Ajovy, a humanized monoclonal antibody, for the prevention of migraine in adults.
SEPTEMBER 18, 2018
